SANTA FE—Yesterday, the New Mexico Medical Cannabis Program’s Medical Advisory Board voted unanimously to add neurodegenerative dementia including Alzheimer’s disease (AD) to the list of medical conditions eligible for the Medical Cannabis Program. The Secretary of Health will have the final decision. Medical cannabis is currently available to Alzheimer’s patients in thirteen of the states that authorize its use.
The Drug Policy Alliance filed the petition on behalf of all New Mexicans who suffer from Alzheimer’s disease. Although Alzheimer’s disease was specifically petitioned for, the board chose to expand their recommendation to include all types of neurodegenerative dementia.
“The Medical Cannabis Advisory Board’s action not only recognizes the debilitating impact neurodegenerative diseases have on New Mexico’s increasing elderly population, it recognizes that medical cannabis should be part of a larger comprehensive approach to support our elders’ quality of life,” stated Emily Kaltenbach, director of the Drug Policy Alliance’s New Mexico office. “New Mexico has a long history of respecting our elders and the Board’s compassionate recommendation to add these conditions is clearly rooted in the great values of our state.”
Alzheimer’s disease, similar to many of the conditions presently included in New Mexico’s Compassionate Use Act, is a neurologic disease and has no known cure. Existing medications provide only temporary relief, without stopping the progression of the disease.
Santa Fe resident and local radio show host, Larry Love, is a caregiver and legal guardian for his mother who suffers from cognitive impairment, a condition often seen before the onset of Alzheimer’s disease. “My mother became part of the medical cannabis program because she has a lot of physical pain, and it helps her with that. Medical cannabis also helps increase her appetite and desire to eat as well as calms and soothes her and allows her to have restful sleep,” said Love. “Other people who suffer from dementia and conditions like Alzheimer’s should be able to participate in New Mexico’s medical cannabis program too. This medicine can improve the quality of life and lessen the suffering of thousands of New Mexican elders.”
Peer reviewed studies suggest that medical cannabis may improve symptoms related to Alzheimer’s disease and support the pharmacological and physiological benefits seen in the use of cannabinoid compounds and whole plant medicine on general symptoms of neurodegeneration.
“Medical cannabis studies have shown that people suffering from Alzheimer’s disease related anorexia and nighttime agitation, increase their body mass and have improved sleep patterns,” said Jessica Gelay, Policy Coordinator for the Drug Policy Alliance. “Additionally, emerging evidence suggests potential for cannabis to be beneficial in reducing inflammation in the brain, a factor that can lead to the onset of Alzheimer’s disease.”
Professor Gary Wenk, of Ohio State University, whose research focuses on chronic brain inflammation and Alzheimer’s began studying cannabis compounds after other pharmaceuticals he studied “consistently failed to reduce inflammation in the brain.” Wenk’s animal study results show cannabis to be “the most potent brain anti-inflammatory available.”
More than 30,000 New Mexicans are currently living with Alzheimer’s disease, and the number is expected to increase to more than 40,000 by 2025. It is the leading cause of dementia among the elderly and is estimated to affect approximately one in nine people of the population over 65 years of age. Racial and cultural disparities are evident when considering the prevalence of AD among elderly New Mexicans. Older Hispanics are one and a half times more likely to have dementia than Anglos. Veterans, who comprise eleven percent of New Mexico’s population, who suffer from PTSD are twice as likely as veterans without PTSD to develop AD or other age-related dementias.
The Drug Policy Alliance (DPA) is the nation’s leading organization of people who believe the war on drugs is doing more harm than good. DPA fights for drug policies based on science, compassion, health and human rights.
We’re not backing down in the face of Trump’s threats.
As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.
Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.
As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.
At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.
Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.
You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.